We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

By LabMedica International staff writers
Posted on 24 Sep 2026

Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. More...

Although PCR is central to case detection, contamination during specimen collection or processing can produce misleading results and affect surveillance and patient management. New findings from the Democratic Republic of the Congo (DRC) show that many mpox PCR-positive results reflected environmental contamination rather than true infection.

The University of Geneva (UNIGE), together with the Institute of Tropical Medicine Antwerp and the National Institute of Biomedical Research in the DRC, analyzed more than 2,700 mpox PCR results from Goma, Kamituga, Kinshasa, and Uvira collected between April 2024 and April 2026. The analysis, published in The Lancet Infectious Diseases on September 15, 2026, indicates that 35% of results reported as PCR-positive likely reflected environmental contamination with mpox viral DNA rather than active infection. The work has implications for outbreak monitoring and individual patient management.

The team examined cycle threshold (CT) values, which are inversely related to the amount of target DNA detected by PCR. Rather than forming a single distribution, CT values consistently separated into two clusters across study sites: one with low CT values consistent with high viral loads and another near the assay’s detection limit. To investigate whether contamination could explain the borderline results, researchers swabbed surfaces within treatment areas at two care centers. Mpox DNA was frequently detected on surfaces inside these areas but not on those outside them, supporting environmental contamination as a likely source of some positive results.

Serological findings further supported this interpretation. Among individuals the model classified as likely false positives, 89% had no detectable antibodies to mpox. In a separate, smaller assessment of patients with suspected mpox, most were found to have other viruses associated with rash, including varicella (chickenpox) and measles, while few tested positive for mpox. The Geneva Center for Emerging Viral Diseases, a World Health Organization collaborating center for diagnostics, contributed to the study and supports countries in strengthening diagnostic practices.

“The first group corresponds to low values, consistent with a high viral load and therefore a genuine active infection. The second cluster sat just at the detection threshold, pointing to an extremely low viral load — atypical for a real infection, but typical of a residual viral trace. What’s striking is that this clear split between the two groups appeared almost identically across all four sites, which is unlikely to be a coincidence,” said Andrew Azman, associate professor at the Institute of Global Health and the Center for Emerging Viral Diseases at the UNIGE Faculty of Medicine.

“The simplest and fastest fix is to lower the PCR positivity threshold. A lower threshold significantly reduces the number of false positives without meaningfully increasing false negatives — a proposal currently under discussion with decision-makers. In the long term, this shows that we need to improve the training of lab staff in low-resource settings like this so they can spot these anomalies in real time, rather than after the acute emergency is over,” added Azman.

Related Links
UNIGE


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.